Valuation: DIAGNOS Inc.

Market Cap 28.3M 19.94M 17.49M 16.12M 15.09M 1.88B 28.88M 194M 74.96M 930M 74.89M 73.25M 3.22B P/E 2025
-6.18x
P/E 2026 -6.51x
Enterprise Value 27.77M 19.57M 17.16M 15.82M 14.81M 1.85B 28.35M 190M 73.57M 913M 73.5M 71.89M 3.16B EV / Sales 2025
293x
EV / Sales 2026 498x
Free-Float
88.96%
Yield 2025 *
-
Yield 2026 -
1 day+4.44%
1 week+1.08%
Current month+2.17%
1 month+6.82%
3 months-12.96%
6 months-32.86%
Current year-37.33%
1 week 0.22
Extreme 0.215
0.24
1 month 0.18
Extreme 0.185
0.26
Current year 0.18
Extreme 0.175
0.38
1 year 0.18
Extreme 0.175
0.42
3 years 0.18
Extreme 0.175
0.59
5 years 0.12
Extreme 0.125
0.6
10 years 0.1
Extreme 0.1
2
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - 01/05/2008
Chief Operating Officer - 16/01/2024
Director TitleAgeSince
Director/Board Member - 21/09/2000
Director/Board Member 72 28/09/2020
Chairman 69 30/10/2025
Date Insider Type Main position Quantity % Market Cap.
06-11Option

Director

250,000 0.2076%
06-11Option

Director

250,000 0.2076%
06-11Option

Chairman

300,000 0.2491%
Change 5-day change 1-year change 3-year change Capi.($)
+4.44%+1.08%+23.68%-35.62% 19.94M
+5.17%+9.04%-6.24%+105.25% 255B
+9.65%+7.18%+11.84%+40.64% 86.29B
-0.68%-1.43%-39.13%-34.49% 80.34B
+2.51%+0.78%-56.35%-57.12% 78.93B
-0.25%-0.59%-40.01%-8.66% 55.03B
-1.46%-0.97%-35.25%-18.60% 44.67B
+0.38%-0.37%-7.60%+75.91% 34.33B
-1.19%-2.74%-36.13%-5.92% 31.57B
+1.01%+1.04%-9.43%+178.80% 31.14B
Average +1.96%+0.03%-19.46%+24.02% 69.76B
Weighted average by Cap. +3.19%+2.97%-19.54%+42.68%

Financials

2025 2026
Net sales 104K 73.16K 64.14K 59.13K 55.35K 6.9M 106K 711K 275K 3.41M 275K 269K 11.83M 65.48K 46.15K 40.46K 37.3K 34.92K 4.35M 66.84K 448K 173K 2.15M 173K 170K 7.46M
Net income -4.29M -3.02M -2.65M -2.44M -2.29M -285M -4.38M -29.35M -11.36M -141M -11.34M -11.1M -488M -4.56M -3.21M -2.81M -2.59M -2.43M -303M -4.65M -31.19M -12.07M -150M -12.06M -11.79M -519M
Net Debt -164K -115K -101K -93.25K -87.3K -10.88M -167K -1.12M -434K -5.38M -433K -424K -18.65M -525K -370K -325K -299K -280K -34.91M -536K -3.6M -1.39M -17.26M -1.39M -1.36M -59.83M
Logo DIAGNOS Inc.
Diagnos Inc. is a Canadian company, which is engaged in the early detection of critical eye-related health problems using advanced technology based on Artificial Intelligence (AI). It markets Computer Assisted Retinal Analysis (CARA), a software platform which assists health specialists in the detection of certain retinopathy pathologies through the computerized analysis of retina images. CARA is an in-house-hosted Web-based application that integrates fundus cameras with an image processing engine over a secure Internet connection. The CARA suite of applications allows an eye care specialist to more clearly visualize both normal retinal landmarks (optic nerve, vascular system, macula, fovea), and pathological changes (exudates, haemorrhages, micro-aneurisms, neo-vascularization). CARA is indicated for use by healthcare professionals in an adult general population in the context of a general eye-health exam.
Employees
22
Date Price Change Volume
26/06/26 CA$0.2350 +4.44% 150,500
25/06/26 CA$0.2250 -1.10% 140,400
24/06/26 CA$0.2275 -1.09% 64,342
23/06/26 CA$0.2300 +2.22% 47,066
22/06/26 CA$0.2250 -3.23% 86,490

Annual profits - Rate of surprise